| 名稱 | FIP1L1(E12)-PDGFRA(E12) Translocation |
| 型號(hào) | CBP20204D |
| 報(bào)價(jià) |  |
| 特點(diǎn) | FIP1L1(E12)-PDGFRA(E12) Translocation |
產(chǎn)品搜索
相關(guān)文章
- ATCC細(xì)胞的貼壁過程有何特點(diǎn)呢？
- 基于納米顆粒的組合免疫療法對(duì)致命性癌癥發(fā)起三重打擊
- PLoS ONE：科學(xué)家發(fā)現(xiàn)癌癥轉(zhuǎn)移的新線索
- 分子診斷標(biāo)準(zhǔn)品，選擇科佰生物
- 泛腫瘤大panel質(zhì)控品升級(jí)，免費(fèi)試用申請(qǐng)中
- 大腦中新發(fā)現(xiàn)的一種淋巴細(xì)胞，能夠清除大腦廢物
- 從“腫瘤免疫療法”發(fā)展，看“單抗、CAR-T”任重而道遠(yuǎn)！
- 腫瘤細(xì)胞上的DNA排列方式探討
- 【靶點(diǎn)模型+診斷質(zhì)控】EGFR vIII的藥物開發(fā)和診斷
- 【靶點(diǎn)模型+診斷質(zhì)控】BTK C481S的藥物開發(fā)和診斷
聯(lián)系我們
聯(lián)系人：蔣經(jīng)理
電話：4008750250
號(hào)碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號(hào)
Email： zhangxiangwen@cobioer.com
電話：4008750250
號(hào)碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號(hào)
Email： zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
基因檢測(cè)標(biāo)準(zhǔn)品 > Translocation > CBP20204DFIP1L1(E12)-PDGFRA(E12) Translocation
- 詳細(xì)內(nèi)容
CBP20204D | |
| Format | DNA |
| Description | FIP1L1, factor interacting with PAPOLA and CPSF1, contributes to poly(A) site processing (PMID: 14749727). FIP1L1 fusions play an important role in the pathogenesis of leukemia (PMID: 24763514), including FIP1L1-PDGFRA in acute myeloid leukemia (PMID: 32269633, PMID: 31450116) and in myeloid/lymphoid neoplasms with eosinophilia (PMID: 31995156), and FIP1L1 fusions with ROS1 has been observed in spitzoid neoplasms (PMID: 31361613). |
| Technical Data | |
| Left Gene | FIP1L1 |
| Left Breakpoint | Chr4:542****1:+ |
| Right Gene | PDGFRA |
| Right Breakpoint | Chr4:5514****:+ |
| Buffer | Tris-EDTA |
| Product Information | |
| Intended Use | Research Use Only |
| Unit Size | 1ug |
| Concentration | Download for COA |
| Purity | Download for COA |
| DNA electrophoresis | Download for COA |
| Sanger sequencing |
|
| Storage | 4℃ |
| Expiry | 36 months from the date of manufacture |
會(huì)員_a.png)